“Keystone Symposia Global Health Series: Pathogenesis and Control of Emerging Infections and Drug Resistant Organisms”, presented at the 2008, Bangkok, Thailand, 2008.
, “Acute Graft-Versus-Host Disease Biomarkers Measured During Therapy Can Predict Treatment Outcomes: A Blood and Marrow Transplant Clinical Trials Network Study”, Blood, vol. 119, pp. 3854-3860, 2012.
, , “Prevalence of Persistent Pain 3 to 5 Years Post Primary Root Canal Therapy and its Impact on Oral Health-Related Quality of Life: PEARL Network Findings”, J Endod, vol. 40, pp. 1917-1921, 2014.
, “Serological Responses to an Avian Influenza A/H7N9 Vaccine Mixed at the Point-of-Use with MF59 Adjuvant: A Randomized Clinical Trial”, JAMA, vol. 312, pp. 1409-1419, 2014.
, “Outcomes in Children Who Underwent Transplantation for Autoimmune Hepatitis”, Liver Transpl, vol. 17, pp. 393-401, 2011.
, “Improvement in Outcomes of Clinical Islet Transplantation: 1999-2010”, in 72nd Scientific Sessions of the American Diabetes Association, Philadelphia, PA, 2012.
, “ABO-Blood Groups and Risk of Abdominal Aortic Aneurysm and Peripheral Obstructive Artery Disease: Two Sides of the Same Coin”, Thromb Res, vol. 129, pp. 89-90, 2012.
, “Background Morbidity in HIV Vaccine Trial Participants From Various Geographic Regions as Assessed by Unsolicited Adverse Events”, Hum Vaccin Immunother, vol. 8, pp. 630-638, 2012.
“Economic Evaluation of Treatment of Macular Edema Due to Central or Hemiretinal Vein Occlusion in the SCORE 2 Trial”, in Association for Research in Vision and Ophthalmology Annual Meeting, Virtual, 2021.
, “Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120,”, Ann Intern Med, vol. 125, p. 270, 1996.
, “A Novel Scoring System, The Cord Blood APGAR, Predicts Engraftment after Cord Blood Transplantation: Optimization of Selection of CBUs for Transplantation.”, in ISCT 2010, Philadelphia, PA, 2010.
, “Total Colony-Forming Units Are a Strong, Independent Predictor of Neutrophil and Platelet Engraftment After Unrelated Umbilical Cord Blood Transplantation: A Single-Center Analysis of 435 Cord Blood Transplants”, Biol Blood Marrow Transplant, vol. 17, pp. 1362-1374, 2011.
, “Most Closely HLA-Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) to Treat Persistent Reactivation or Infection with Adenovirus, CMV and EBV after Hemopoietic Stem Cell Transplantation (HSCT).”, in American Society of Hematology 52nd Annual Meeting and Exposition, Orlando, Fl, 2010.
, “Safety and Immunogenicity of Modified Vaccinia Ankara in Hematopoietic Stem Cell Transplant Recipients: A Randomized, Controlled Trial”, J Infect Dis, vol. 207, pp. 1888-1897, 2013.
, “Time Sensitive Parameters of Immune Reconstitution Measured Between Day 100 and 1 Year Predict Survival After Unrelated Cord Blood Transplant (UCBT): The Dynamic Impact of Dendritic Cells, Tregs, and Thymic Recovery.”, in European Society of Hematology World Cord Blood Congress, Marseille, 2010.
, “Reticular Drusen as a Baseline Risk Factor for Progression to Advanced AMD in AREDS”, presented at the 01/05/2005, Fort Lauderdale, FL, 2005.
, , “One-Unit Versus Two-Unit Cord-Blood Transplantation for Hematologic Cancers”, N Engl J Med, vol. 371, pp. 1685-1694, 2014.
, , , “Differential Impact of HLA-A, -B, and -DRB1 Mismatching in Relation to Other Variables on the Outcomes of Myeloablative Unrelated Single Donor Umbilical Cord Blood Transplantation From 4/6 Matched Units in Children and Young Adults”, presented at the 2011, Honolulu, HI, 2011, vol. 17 No 2 Su, pp. S 185 - 186.
, “Differential Effects of Antiepileptic Drugs on Neonatal Outcomes”, Epilepsy Behav, vol. 24, pp. 449-456, 2012.
, “Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO)”, presented at the 2008, Fort Lauderdale, FL, 2008.
, “Risk Factors Associated With Incident Cataracts and Cataract Surgery in the Age-Related Eye Disease Study (AREDS): AREDS Report Number 32”, Opthalmology, vol. 118, pp. 2113-2119, 2011.
, Modify or remove your filters and try again.